Synthesis and Molecular Docking Analysis of New Thiazo-isoindolinedione Hybrids as Potential Inhibitors of the SARS-CoV-2 Main Protease

被引：3
|
作者：
Shaaban, Saad [1 ,2 ]
Al-Karmalawy, Ahmed A. [3 ]
Alhamzani, Abdulrahman G. [4 ]
Abou-Krisha, Mortaga M. [4 ,5 ]
Al-Qudah, Mahmoud A. [4 ,6 ]
Yousef, Tarek A. [4 ,7 ]
机构：
[1] King Faisal Univ, Dept Chem, Coll Sci, Al Hasa 31982, Saudi Arabia
[2] Mansoura Univ, Dept Chem, Fac Sci, Mansoura 35516, Egypt
[3] Ahram Canadian Univ, Dept, Fac Pharm, Giza 12566, Egypt
[4] Imam Mohammad Ibn Saud Islam Univ, Dept Chem, Coll Sci, Riyadh 11623, Saudi Arabia
[5] Yarmouk Univ, Dept Chem, Fac Sci, POB 566, Irbid 21163, Jordan
[6] South Valley Univ, Dept Chem, Qena 83523, Egypt
[7] Minist Justice, Dept Toxic & Narcot Drug, Forens Med, Medicolegal Org,Mansoura Lab, Cairo, Egypt
来源：
ORIENTAL JOURNAL OF CHEMISTRY | 2023年 / 39卷 / 04期
关键词：
Condensation; COVID-19; Isoindolinedione; Thiazolidinedione; Molecular docking;
D O I：
10.13005/ojc/390412
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Herein, we report the synthesis of novel thiazo-isoindolinedione derivatives in excellent yields (up to 92%) from the reaction of thiazolidinedione and isoindoline-dione. The structures of the novel compounds were elucidated by H-1-, C-13-NMR, and MS analyses. Furthermore, molecular docking analysis was performed to study the potential inhibition of the SARS-CoV-2 main protease (M-pro) by the new thiazo-isoindolinediones. The present study revealed that the new thiazo-isoindolinediones could inhibit the Mpro and represent a promising platform for the experimental development of new antiviral drugs based on thiazo-isoindolinedione scaffolds.
引用
收藏
页码：913 / 918
页数：6
相关论文
共 50 条
  • [41] Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease
    Banerjee, Arkadeep
    Gosavi, Shachi
    JOURNAL OF PHYSICAL CHEMISTRY B, 2023, 127 (04): : 855 - 865
  • [42] In Silico Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Hernandez-Serda, Manuel Alejandro
    Vazquez-Valadez, Victor H.
    Aguirre-Vidal, Pablo
    Markarian, Nathan M.
    Medina-Franco, Jose L.
    Cardenas-Granados, Luis Alfonso
    Alarcon-Lopez, Aldo Yoshio
    Martinez-Soriano, Pablo A.
    Velazquez-Sanchez, Ana Maria
    Falfan-Valencia, Rodolfo E.
    Angeles, Enrique
    Abrahamyan, Levon
    PATHOGENS, 2024, 13 (10):
  • [43] In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
    Abdelrady, Yousef A.
    Ashraf, Naeem Mahmood
    Hamid, Arslan
    Thabet, Hayam S.
    Sayed, Asmaa M.
    Salem, Shimaa H.
    Hassanein, Emad H. M.
    Sayed, Ahmed M.
    FUTURE VIROLOGY, 2023, 18 (05) : 295 - 308
  • [44] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Soumya Gulab Katre
    Alpana Jagdish Asnani
    Kumar Pratyush
    Nilima Gangadhar Sakharkar
    Ashwini Gajanan Bhope
    Kanchan Tekram Sawarkar
    Vaibhav Santosh Nimbekar
    Future Journal of Pharmaceutical Sciences, 8
  • [45] Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies
    Gupta, Sanjay
    Singh, Atul Kumar
    Kushwaha, Prem Prakash
    Prajapati, Kumari Sunita
    Shuaib, Mohd
    Senapati, Sabyasachi
    Kumar, Shashank
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (12): : 4334 - 4345
  • [46] Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
    Mengist, Hylemariam Mihiretie
    Dilnessa, Tebelay
    Jin, Tengchuan
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [47] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Katre, Soumya Gulab
    Asnani, Alpana Jagdish
    Pratyush, Kumar
    Sakharkar, Nilima Gangadhar
    Bhope, Ashwini Gajanan
    Sawarkar, Kanchan Tekram
    Nimbekar, Vaibhav Santosh
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 8 (01)
  • [48] Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease
    Banerjee, Arkadeep
    Gosavi, Shachi
    PROTEIN SCIENCE, 2021, 30 : 46 - 47
  • [49] Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
    Omer, Samia E.
    Ibrahim, Tawasol M.
    Krar, Omer A.
    Ali, Amna M.
    Makki, Alaa A.
    Ibraheem, Walaa
    Alzain, Abdulrahim A.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 29
  • [50] Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
    Cheng, Bijun
    Li, Tianjiao
    BIOTECHNIQUES, 2020, 69 (02) : 109 - +
12345